Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CHAITAN PHD KHOSLA Insider Profile
4 Followers
CHAITAN PHD KHOSLA, Director at Protagonist Therapeutics, holds 25.33K shares in Entero Therapeutics (Ticker: ENTO), holds 0.00 shares in Protagonist Therapeutics (Ticker: PTGX).
CHAITAN PHD KHOSLA has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that CHAITAN PHD KHOSLA holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by CHAITAN PHD KHOSLA
CHAITAN PHD KHOSLA's Trading History
Protagonist Therapeutics
Aug 12, 2020
Director
Uninformative Buy
4.72K
$0.00
Entero Therapeutics
Jun 12, 2024
Director
Uninformative Buy
―
$12.79K
List of latest transactions for each holding click on a transaction to see CHAITAN PHD KHOSLA's performance on stock
You May Also Like
CHAITAN PHD KHOSLA insider profile FAQ
What is the percentage of profitable transactions made by CHAITAN PHD KHOSLA?
The percentage of profitable transactions made by CHAITAN PHD KHOSLA is ―.
What is the average return per transaction made by CHAITAN PHD KHOSLA?
The average return per transaction made by CHAITAN PHD KHOSLA is ―.
What stocks does CHAITAN PHD KHOSLA hold?
CHAITAN PHD KHOSLA holds: PTGX, ENTO stocks.
What was CHAITAN PHD KHOSLA’s latest transaction?
CHAITAN PHD KHOSLA latest transaction was an Uninformative Buy of ―.
What was CHAITAN PHD KHOSLA's most profitable transaction?
CHAITAN PHD KHOSLA’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is CHAITAN PHD KHOSLA's role in Protagonist Therapeutics?
CHAITAN PHD KHOSLA's role in Protagonist Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.